Finance

Lists
Why is PHAR up 5,54%?
Dive Deeper
PHAR:NASDAQ
Pharming Group NV - ADR
9,62 US$
+5,54%
(+0,51) 1D
20 ოქტ, 11:07:19 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
9,39 US$
High
9,65 US$
Low
9,34 US$
Mkt. cap
601,14 მლნ.
Avg. vol.
27,72 ათ.
Volume
3,01 ათ.
52-wk high
21,34 US$
52-wk low
9,11 US$
Beta
-0,04
Shares outstanding
70,78 მლნ.
No. of employees
407
Open
9,39 US$
High
9,65 US$
Low
9,34 US$
Mkt. cap
601,14 მლნ.
Avg. vol.
27,72 ათ.
Volume
3,01 ათ.
52-wk high
21,34 US$
52-wk low
9,11 US$
Beta
-0,04
Shares outstanding
70,78 მლნ.
No. of employees
407
News stories
From web sources and news partners
About Pharming Group NV - ADR
CEO-
Employees407
Founded1988
Headquarters-
Sector-
Websitepharming.com
Analyst ratings
Based on 2 analysts giving stock ratings to PHAR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current 9,62 US$
38,00 US$ (+295,22%)
Average
37,50 US$ (+290,02%)
Lowest
37,00 US$ (+284,82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Reiterated
38,00 US$
+295,2%
10/14/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
37,00 US$
+284,8%
10/14/2026
Jeff Jones
Oppenheimer
Buy
Maintained
40,00 US$
+316%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
97,29 მლნ.
106,53 მლნ.
72,45 მლნ.
90,21 მლნ.
Cost of goods sold
7,07 მლნ.
21,13 მლნ.
6,64 მლნ.
14,54 მლნ.
Cost of revenue
7,07 მლნ.
21,13 მლნ.
6,64 მლნ.
14,54 მლნ.
Research and development expenses
21,28 მლნ.
32,05 მლნ.
25,56 მლნ.
32,26 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43,08 მლნ.
50,67 მლნ.
45,53 მლნ.
43,52 მლნ.
Operating expense
64,29 მლნ.
82,37 მლნ.
70,71 მლნ.
74,36 მლნ.
Total operating expenses
71,36 მლნ.
103,50 მლნ.
77,36 მლნ.
88,90 მლნ.
Operating income
25,92 მლნ.
3,03 მლნ.
-4,91 მლნ.
1,31 მლნ.
Other non operating income
1,88 მლნ.
403,00 ათ.
-
-32,00 ათ.
EBT including unusual items
12,76 მლნ.
4,80 მლნ.
-4,75 მლნ.
3,04 მლნ.
EBT excluding unusual items
22,86 მლნ.
1,61 მლნ.
-4,75 მლნ.
3,04 მლნ.
Income tax expense
5,21 მლნ.
-528,00 ათ.
459,00 ათ.
1,40 მლნ.
Effective tax rate
40,83%
-11,00%
-9,65%
46,12%
Other operating expenses
-71,00 ათ.
-348,00 ათ.
-377,00 ათ.
-1,42 მლნ.
Net income
7,55 მლნ.
5,33 მლნ.
-5,21 მლნ.
1,64 მლნ.
Net profit margin
7,76%
5,00%
-7,20%
1,82%
Earnings per share
0,01
0,01
-0,07
0,00
Interest and investment income
-
4,50 მლნ.
3,24 მლნ.
-
Interest expense
-9,21 მლნ.
-
-2,70 მლნ.
-4,10 მლნ.
Net interest expenses
-9,21 მლნ.
4,50 მლნ.
542,00 ათ.
-4,10 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
30,12 მლნ.
6,24 მლნ.
-1,80 მლნ.
2,67 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები